Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 2,241 | 2,895 | 2,383 | 773 | 1,989 |
| Operating Income | -2,241 | -2,895 | -2,383 | -773 | -1,989 |
| Other Income | 116 | 104 | 64 | 27 | 20 |
| Pre-tax Income | -2,125 | -2,791 | -2,319 | -746 | -1,970 |
| Net Income Continuous | -2,125 | -2,791 | -2,319 | -746 | -1,970 |
| Net Income | $-2,125 | $-2,791 | $-2,319 | $-746 | $-1,970 |
| EPS Basic Total Ops | -0.17 | -0.22 | -0.18 | -0.06 | -0.15 |
| EPS Basic Continuous Ops | -0.17 | -0.22 | -0.18 | -0.06 | -0.15 |
| EPS Diluted Total Ops | -0.17 | -0.22 | -0.18 | -0.06 | -0.15 |
| EPS Diluted Continuous Ops | -0.17 | -0.22 | -0.18 | -0.06 | -0.15 |
| EBITDA(a) | $-2,240 | $-2,894 | $-2,382 | $-772 | $-1,988 |